Roche Diagnostics Sees Data Sourcing, AI and Partnerships As Paving The Way to Personalized Health Care, But Challenges Remain

Two Roche Diagnostics executives outlined the company's vision toward personalized health care. Machine learning, partnerships and data sourcing are key. 

AI Microchips Medicina Modern Digital Equipment Integration concept. Artificial Intelligence Medical Information Technology. Doctor using tablet computer and selects cpu chip icon with head ai. - Image
(Shutterstock)

Two Roche Diagnostics Corp. executives recently spoke enthusiastically about the company's progress toward personalized health care. Central to unlocking this potential is the combination of using data from multiple sources, the use of machine learning to further knowledge and understanding and partnering with others, including non-traditional players, to combine their expertise with Roche's. 

"We're at a pivotal moment [in health care] and we're seeing a real convergence of medical knowledge, technology and data...

More from Strategy

More from Business

Novel Pathway For Combined Drug/IVD Trials Wins Backing Of EU Nations

 
• By 

Broad participation by EU member states in a new pilot to test a unified procedure for evaluating applications for combined drug and IVD studies shows they recognize its value, says Monique Al, vice-chair of the Clinical Trials Coordination Group.

‘Be Quick, But Don’t Hurry’: Dexcom CEO Talks CGM Market Success

 
• By 

Dexcom’s CEO Kevin Sayer discusses this fall’s planned launch of the 15-day G7 CGM, downplays Abbott’s dual-sensor while focusing on development of multi-analyte G8, making OTC Stelo app more “consumerish” for Europeans, and more.

Medtronic’s ‘Strategic Expansion’ Into Remote Monitoring

 

“The Corsano wearable strengthens Medtronic’s acute care and monitoring portfolio,” Marc De Martini, vice president at Medtronic, told Medtech Insight.